SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt incorporates new subsidiary

05 Jul 2021 Evaluate

Wockhardt has incorporated a new subsidiary namely Wockhardt Biologics under the provisions of the Companies Act, 2013 on July 2, 2021. The Authorised, subscribed and paid-up capital of the Wockhardt Biologics is Rs 5,00,000 divided into 50,000 equity shares of Rs 10 each out of which Wockhardt will hold approximately 65% of the total share capital while the remaining stake will be held by certain Promoter Group/ Group entities.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1993.65 -30.20 (-1.49%)
05-Aug-2026 12:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1940.05
Dr. Reddys Labs. 1172.45
Cipla 1450.80
Lupin 2378.70
Zydus Lifesciences 1109.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: